Biofrontera received manufacturing and distribution license
Biofrontera AG announces, that its subsidiary Biofrontera Pharma GmbH received the permission to import pharmaceutical products, clear them for European sales and distribute them.
The responsible district government has inspected the Company, assessing all requirements for granting the manufacturing and distribution license in accordance with the German pharmaceutical law. Biofrontera has sufficient qualified personnel, appropriate rooms and facilities as well as a complex quality management system for importing, approving, storing and distributing pharmaceutical compounds.
The manufacturing license is needed for the European submission of the marketing authorization of BF-200 ALA, planned for the beginning of September. By obtaining the license Biofrontera fulfils another important precondition for a marketing authorization application in the centralized European procedure.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.